Mr. C S Muralidharan is a Cost & Management Accountant with a Master’s degree in Commerce and has completed the Executive Program in General Management from Booth School of Business, University of Chicago.
Mr. Muralidharan has overall 40 years of corporate experience spread across hydro-carbon and pharmaceutical sectors. He has held various board and senior leadership positions across multiple entities in India, Asia and Europe. He has had proactive engagements with the Board demonstrating strong partnership on Strategy M&A transactions, enterprise risk management, capital restructuring, enterprise transformation and ESG initiatives. He has previously worked with organizations like Indian Oil Corporation Limited, Ranbaxy Group, Lupin Limited, Matrix Laboratories Limited, Watson Group and in his last role, was associated with Sun Pharmaceutical Industries Limited, as Group Chief Financial Officer, where he was responsible for global finance, strategy, M&A, investor relations, governance and compliance.